<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">
drop-orange300

2021 Virtual GO2 Foundation Centers of Excellence Summit

 

Dates: 
October 13th-15th

 

Visit Virtual Booth

Module heading text

 

One simple draw.
Two ways to help quickly and accurately decipher the risk of malignancy of a lung nodule.

nodifylung-654

Nodify Lung™ testing consists of two blood-based proteomic tests (the Nodify CDT™ & Nodify XL2® tests) to help physicians reclassify risk of cancer and aid in stratifying patients into distinct nodule management pathways: intervention or surveillance.

 

Learn More

Biodesix Lung Color Logo

Biodesix Lung Reflex® testing consists of the GeneStrat® tumor profiling test and the VeriStrat® immune profiling test to provide physicians with timely molecular results to facilitate treatment decisions for patients with non-small cell lung cancer.

 

Learn More
biopharma-services

We provide biopharmaceutical companies with end-to-end diagnostic services inclusive of diagnostic research and feasibility, assay development, clinical trial testing, and commercialization of companion diagnostics.

 

Learn More

Contact us with any questions

REACH OUT TO OUR TEAM